FINWIRES · TerminalLIVE
FINWIRES

Zoetis' Simparica Trio Gets FDA Emergency Use Authorization for New World Screwworm

By

Zoetis' (ZTS) Simparica Trio, which includes sarolaner, moxidectin, and pyrantel chewable tablets, has received emergency use authorization for the treatment of New World screwworm infestations in dogs and puppies, the US Food and Drug Administration said Thursday.

The FDA said Simparica Trio may be effective in treating New World screwworm infestations in dogs and puppies, adding that Simparica Trio is not authorized for the prevention of New World screwworm.

The emergency use authorization will be effective until it is revoked or the Health and Human Services Secretary terminates the declaration of the potential public health emergency presented by New World screwworm.

Price: $74.31, Change: $+0.77, Percent Change: +1.05%

Related Articles

Wire

GBM Resources Confirms Continuation of Prospective Gold Host at Queensland Project; Shares Down 5%

GBM Resources (ASX:GBM) confirmed the continuation of the prospective Milled Matrix Breccia host horizon at least 700 meters south of the 309 mineral resource at the Stella prospect, expanding the exploration footprint at the Twin Hills project in Queensland, according to a Thursday filing with the Australian bourse.The company intersected gold mineralization during step-out drilling, with assays returning 8 meters at 1.31 grams per tonne grade of gold from 126 meters, the filing said.Further assays are expected to be released in the next two weeks, per the filing.Shares fell 5% in midday trade Thursday.

ASX:GBM
Wire

Pan American Silver Q2 Adjusted Earnings, Revenue Rise; Shares Drop After Hours

Pan American Silver (PAAS) reported Q2 adjusted earnings late Wednesday of $0.73 per basic share, up from $0.43 a year earlier.Analysts polled by FactSet expected $0.88.Revenue for the quarter ended June 30 rose to $1.12 billion from $812 million a year earlier.Three analysts expected $1.15 billion.The company raised its quarterly dividend to $0.184 a share from $0.18, payable around Sept. 4 to stockholders of record Aug. 24.Pan American Silver shares fell 5.1% in after-hours trading.

$PAAS
Wire

Stantec Q2 Adjusted Earnings, Revenue Rise

Stantec (STN) reported Q2 adjusted earnings late Wednesday of 1.61 Canadian dollars ($1.15) per diluted share, up from CA$1.36 a year earlier.Analysts surveyed by FactSet expected CA$1.58.Net revenue in the three months ended June 30 rose to CA$1.78 billion from CA$1.6 billion a year earlier.Analysts projected CA$1.79 billion.Stantec shares rose 1.3% in after-hours trading.

$STN